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Objectives
 Describe the legal challenge that existed for
Colorado’s IP clinical education
 Our strategies to address the challenge, including:
» Gather background information
» Identify stakeholders and engage potential collaborators
» Explore potential solutions

 Review the Colorado story and results

Pharmacy-based challenges of
clinical IPE in Colorado
 Pharmacy is an anomaly as it is the only health
profession requiring student licensure → Student
intern
 Statute in Colorado required a pharmacist to
supervise interns, thus necessitating a licensed
pharmacist be present for each IPE experience

The desired outcome
Allow pharmacy interns to participate fully in patient
care activities when led by any member of the
interprofessional health care team

Gather background information
 NABP model practice act
 ACPE accreditation standards
 Is pharmacy intern licensure desirable and/or
necessary?
» 5 states (encompassing 14 schools of
pharmacy) do not require intern licensure

Identify stakeholders and engage
potential collaborators
 State Board of Pharmacy & DOR
 Colorado Pharmacy Coalition
» Practitioners
» Pharmacy business community
 Health professions schools
 The public

Explore potential solutions
 Utilize educational work-arounds
 Explore possible interpretations of current statute
 Clarify the state practice act
 Change the law
We decided to change the
law!

The Colorado Story
 Used existing opportunity of periodic statute review
mandated by Colorado
 Enlisted University lobbyists to assist
 There were concerns from other professions about
competition for practice sites
 DOR concerned about undermining need for
licensed professionals

Success!
 An intern under the direct and immediate supervision of a
pharmacist may engage in the practice of pharmacy
 An intern, as defined in section 12- 42.5-102(17)(a), engaged in
the practice of pharmacy within the curriculum of a school or
college of pharmacy in accordance with section 12-42.5102(17)(a), may be supervised by a manufacturer registered
pursuant to section 12-42.5-112 or by another regulated
individual as provided for in rules adopted by the board

Pharmacy Intern Supervision
 State Board identified 12 health professionals
including: (MD, PA, RN, NP, DDS, etc.)
 Overlap in scope of practice must exist between
pharmacy student and supervising profession
 State Board allowed accreditation standards to
regulate the training concerns of pharmacy
students

Impact on IPE practice settings
 Increased integration of interprofessional training
Impact on Clinical Offerings

Site

Student Capacity

New P4 IP Primary Care Elective Rotations

2 clinics

10 – 15 / year

Expanded roles for P4 students in
underserved clinics

5 clinics

35 - 40 students / year

6 communities

25 - 35 students / year

3 sites

80 students / year

Collaborative precepting between
community pharmacy and health centers
Integration of early pharmacy learners into
primary care clinics

Impact on IPE practice settings
 Students at the primary care sites reported an
average of
» 10.55 direct patient encounters (seeing patients, followup communications) per day
» 28.1 indirect patient encounters (reviewing patient
charts)
» 3.5 non-patient care activities (time engaged with
preceptor)

Conclusion
 Changing law allowed more pharmacy students to
contribute to IP patient care practices
 Addressing legal barriers to IP clinical education
legislatively is possible and may be necessary to
support health professions students in their
requirements to learn in new team-based care
delivery models

